Team:INSA-Lyon/Project/Stage2/Results

From 2010.igem.org

(Difference between revisions)
(New page: <!-- {{INSA-Lyon_style}} --> {{INSA-Lyon/stylegroningen}} {{INSA-Lyon/header}} {{INSA-Lyon/maincontent}} {{INSA-Lyon/menugauche}} {{INSA-Lyon/menudroppy2}} <html xmlns="http://www.w3.org...)
 
(13 intermediate revisions not shown)
Line 15: Line 15:
}
}
ul#topnav li span { background: #f200d0;}
ul#topnav li span { background: #f200d0;}
 +
#list_extra{list-style-type:circle; margin: 10px auto auto 100px;}
 +
#list_extra2{list-style-type:circle;}
 +
#table1{margin: 10px auto auto 30px;
 +
      border-collapse: collapse;
 +
      text-align: center;}
 +
#table1 td,#table1 th /* Mettre une bordure sur les td ET les th */
 +
{border: 2px solid black;}
 +
.image {width: 300px; height: 400px; margin:10px}
</style>
</style>
Line 34: Line 42:
<div id="corps2">
<div id="corps2">
-
<h3>Results 2</h3>
+
<h2>Results</h2>
<p>
<p>
-
<br><p>Lorem ipsus etc.
+
<br><h3><font color="purple">Observation of the phasin-intein fusion protein (BBa_K342002) on the granule</font></h3><br><br>
-
<a href="https://2010.igem.org/wiki/index.php?title=Team:INSA-Lyon/Project/Stage2/Strategy/storagelipids"><font color="black"><i><u>Storage of lipids</u></i><font></a>
+
<p>Our ligation didn't work out so we couldn't realize the observations as planned.<br/>
 +
We had many difficulties to add the constitutive promoter despite numerous tries.</p> <br><br>
 +
<br><h3><font color="purple">Lipidic inclusion in the PHB drop</font></h3><br><br>
 +
<p>We made a double transformation with pILI1 and 20N: The resultant bacteria synthesize the PHB drops and over synthesize the licopen.
 +
<br/><br/>
 +
<p>When we obtained the clones, we started four different series of cultures in order to analyze the will of the lipid when the granule are produced.<br/>
 +
<ol id="list_extra">
 +
<li>Serie 1 : in  LB media with glucose 7% and 2,5µg of  RedNile<br/>
 +
<ol id="list_extra">
 +
<li> pILI1 with ampiciline</li>
 +
<li>double transformation with ampicillin</li>
 +
<li>double transformation with ampicillin and kanamycin</li>
 +
<li>The lipid part with kanamycin</li>
 +
</ol><br>
 +
<li>Serie 2 : in  LB media with 2,5µg of RedNile<br/>
 +
<ol id="list_extra">
 +
<li> pILI1 with ampicillin</li>
 +
<li>double transformation with ampicillin</li>
 +
<li>double transformation with ampicillin and kanamycin</li>
 +
<li>The lipid part with kanamycin</li>
 +
</ol><br>
 +
<li>Serie 3 : in  LB media with glucose 7%<br/>
 +
<ol id="list_extra">
 +
<li> pILI1 with ampicillin</li>
 +
<li>double transformation with ampicillin and kanamycin</li>
 +
<li>The lipid part with kanamycin</li>
 +
</ol><br>
 +
<li>Serie 4 : in LB media, the double transformation with ampicillin and kanamycin</li>
 +
</ol><br/>
 +
 
 +
<p>We observed a sample of each culture under fluorescence microscope. Unfortunately we couldn't see the difference between the granules and the licopen.<p>
</p><br>
</p><br>
</div>
</div>
-
 
+
<p style="text-align:center;"><a href="#top">Top of Page</a></p>
<div id="corps4" style="border:0px;">
<div id="corps4" style="border:0px;">

Latest revision as of 00:36, 28 October 2010




Results


Observation of the phasin-intein fusion protein (BBa_K342002) on the granule



Our ligation didn't work out so we couldn't realize the observations as planned.
We had many difficulties to add the constitutive promoter despite numerous tries.




Lipidic inclusion in the PHB drop



We made a double transformation with pILI1 and 20N: The resultant bacteria synthesize the PHB drops and over synthesize the licopen.

When we obtained the clones, we started four different series of cultures in order to analyze the will of the lipid when the granule are produced.

  1. Serie 1 : in LB media with glucose 7% and 2,5µg of RedNile
    1. pILI1 with ampiciline
    2. double transformation with ampicillin
    3. double transformation with ampicillin and kanamycin
    4. The lipid part with kanamycin

  2. Serie 2 : in LB media with 2,5µg of RedNile
    1. pILI1 with ampicillin
    2. double transformation with ampicillin
    3. double transformation with ampicillin and kanamycin
    4. The lipid part with kanamycin

  3. Serie 3 : in LB media with glucose 7%
    1. pILI1 with ampicillin
    2. double transformation with ampicillin and kanamycin
    3. The lipid part with kanamycin

  4. Serie 4 : in LB media, the double transformation with ampicillin and kanamycin

We observed a sample of each culture under fluorescence microscope. Unfortunately we couldn't see the difference between the granules and the licopen.


Top of Page